Cinven Sells Minority Stakes in SYNLAB; Labcorp and Elliott Become Minority Investors

Cinven Acquires Majority Stake in BioAgilytix; Cobepa Reinvests

December 20, 2021

Healthcare Services

International private equity firm Cinven has agreed to acquire a majority stake in BioAgilytix through a recapitalization, with current investor Cobepa remaining a significant minority investor. GHO Capital has realised its investment and will exit; the transaction will provide funding to support BioAgilytix’s international expansion, capacity and capability investments, and buy-and-build strategy in large-molecule bioanalytical services. BioAgilytix is headquartered in Durham, North Carolina and employs about 870 staff across the United States, Europe and Australia.

Bain Capital and Cinven to Acquire Lonza Specialty Ingredients

February 8, 2021

Manufacturing

Bain Capital Private Equity and Cinven have entered into definitive agreements to acquire Lonza Specialty Ingredients (LSI), a division of Lonza AG, for a total enterprise value of CHF 4.2 billion. LSI, headquartered in Basel, Switzerland, is a global provider of specialty chemicals for microbial control with ~2,800 employees, and the consortium intends to invest in R&D, bolster production capabilities and use LSI as a platform for buy-and-build consolidation in the sector; the transaction was expected to close in H2 2021.

Abenex Invests in Santis LAB

September 23, 2024

Food & Beverage

Abenex has completed a minority growth investment in Santis LAB, a Franco‑Swiss laboratory that develops and markets food supplements sold through a network of roughly 2,000 pharmacies. The founders and management will remain operational and are investing alongside Abenex to support Santis' expansion into adjacent markets and new geographies.

Cinven to acquire majority stake in Euro Techno Com Group from Carlyle

June 3, 2022

Telecommunications

Cinven has entered into exclusive negotiations to acquire a majority stake in Euro Techno Com Group (ETC Group), a France‑headquartered distributor of telecom and technology infrastructure products, from Carlyle. Founder and CEO Cédric Varasteh would retain a significant stake and Carlyle will reinvest as a minority shareholder; the Group has around 1,100 employees and generates more than €1 billion in annual revenues.

Astorg and Cinven Acquire LGC

November 21, 2019

Healthcare Services

A consortium led by private equity firms Astorg and Cinven has signed an agreement to acquire LGC, a UK-headquartered global leader in life sciences tools. The buyout will back LGC’s continued organic growth and M&A-led expansion across its standards, genomics and laboratory services businesses; financial terms were not disclosed and the transaction remains subject to regulatory approvals.

Novo Holdings Acquires Ellab from EQT Private Equity

June 21, 2023

Medical Devices

Novo Holdings A/S has agreed to acquire Ellab from EQT Mid Market Europe (EQT Private Equity); the deal was announced in June and subsequently completed following regulatory approvals. Headquartered in Hillerød, Denmark, Ellab is a provider of validation and monitoring hardware, software and services for the biotech and pharmaceutical industries; the Lundbeck Foundation has also agreed to acquire a significant minority stake.